News & Articles

Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and drug development programs

SelectScience brings you scientific and technical takeaways from the 2018 AACR Annual Meeting

Boosting T cell memory may result in long-lasting and effective responses for patients treated with checkpoint blockade immunotherapies

CYC065, an inhibitor of CDK2 and CDK9 kinases, has inhibited tumor growth in some patients with advanced cancers

The personal genomics product will focus on 59 genes identified by the American College of Medical Genetics and Genomics

First human trials examine the impact of dark chocolate consumption on cognition and other brain functions

AACR and CRUK, two of the biggest cancer research committees around the globe to join force to aid the development of cancer therapeutics

The highly anticipated platform was launched by Repositive at AACR annual meeting

NYU school of medicine becomes the most recent cancer center to join PanFAM-1 prospective study

The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer

The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer

Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer